Publication | Closed Access
Platelet × CRP Multiplier Value as an Indicator of Poor Prognosis in Patients With Resectable Pancreatic Cancer
29
Citations
31
References
2016
Year
Thrombocytosis and CRP influenced pancreatic cancer patient prognosis. Platelet × CRP multiplier is assumed as a useful parameter that reflects the contribution of activated platelets to cancer progression.
| Year | Citations | |
|---|---|---|
Page 1
Page 1